Skip to content
10-Q

Quarterly Report

BIOSPECIFICS TECHNOLOGIES CORP

0001140361-20-011266

← back to feed
Filed
May 11, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2020 · May 11, 2020 7.34M sh
Shares Diluted Q1 2020 · Mar 31, 2020 7.36M sh
Shares Diluted Q1 2020 · Mar 31, 2019 7.34M sh
Stock Repurchased Q1 2020 · Mar 31, 2020 $221.03K
Stock Repurchased Q1 2020 · Mar 31, 2019 $0
Capex Q1 2020 · Mar 31, 2020 $69.47K
Capex Q1 2020 · Mar 31, 2019 $0
Operating Cash Flow Q1 2020 · Mar 31, 2020 $8.22M
Operating Cash Flow Q1 2020 · Mar 31, 2019 $6.04M
Short Term Investments Q1 2020 · Mar 31, 2020 $85.08M
Short Term Investments Q1 2020 · Dec 31, 2019 $84.24M
Cash And Equivalents Q1 2020 · Mar 31, 2020 $19.13M
Cash And Equivalents Q1 2020 · Dec 31, 2019 $5M
Stockholders Equity Q1 2020 · Mar 31, 2020 $129.27M
Stockholders Equity Q1 2020 · Dec 31, 2019 $124.49M
Stockholders Equity Q1 2020 · Mar 31, 2019 $102.21M
Stockholders Equity Q1 2020 · Dec 31, 2018 $97.59M
Current Liabilities Q1 2020 · Mar 31, 2020 $3.35M
Current Liabilities Q1 2020 · Dec 31, 2019 $1.42M
Total Liabilities Q1 2020 · Mar 31, 2020 $3.98M
Total Liabilities Q1 2020 · Dec 31, 2019 $2.16M
Current Assets Q1 2020 · Mar 31, 2020 $122.87M
Current Assets Q1 2020 · Dec 31, 2019 $109.27M
Total Assets Q1 2020 · Mar 31, 2020 $133.25M
Total Assets Q1 2020 · Dec 31, 2019 $126.65M
Eps Diluted Q1 2020 · Mar 31, 2020 $0.61
Eps Diluted Q1 2020 · Mar 31, 2019 $0.60
Eps Basic Q1 2020 · Mar 31, 2020 $0.61
Eps Basic Q1 2020 · Mar 31, 2019 $0.61
Sga Expense Q1 2020 · Mar 31, 2020 $3.17M
Sga Expense Q1 2020 · Mar 31, 2019 $2.91M
Rd Expense Q1 2020 · Mar 31, 2020 $121.97K
Rd Expense Q1 2020 · Mar 31, 2019 $149.54K
Net Income Q1 2020 · Mar 31, 2020 $4.5M
Net Income Q1 2020 · Mar 31, 2019 $4.42M
Operating Income Q1 2020 · Mar 31, 2020 $5.23M
Operating Income Q1 2020 · Mar 31, 2019 $5.07M
Revenue Q1 2020 · Mar 31, 2020 $9.67M
Revenue Q1 2020 · Mar 31, 2019 $8.13M